Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

被引:265
|
作者
Hoste, Levi [1 ,2 ]
Van Paemel, Ruben [3 ,4 ,5 ]
Haerynck, Filomeen [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Pulmonol Infect Dis & Immunol, Ghent, Belgium
[2] Ghent Univ Hosp, Primary Immunodeficiency Res Lab, Ctr Primary Immunodeficiency Ghent, Jeffrey Modell Diag & Res Ctr, Ghent, Belgium
[3] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[4] Canc Res Inst Ghent CRIG, Ghent, Belgium
[5] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium
关键词
PIMS-TS; MIS-C; COVID-19; SARS-CoV-2; MIMICKING KAWASAKI-DISEASE; SARS-COV-2; PIMS-TS; MIS-C; INVOLVEMENT; SHOCK; INFECTION; DIAGNOSIS;
D O I
10.1007/s00431-021-03993-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases. Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial. What is Known: A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis. What is New: This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.
引用
收藏
页码:2019 / 2034
页数:16
相关论文
共 50 条
  • [41] Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience
    Riollano-Cruz, Mariawy
    Akkoyun, Esra
    Briceno-Brito, Eudys
    Kowalsky, Shanna
    Reed, James
    Posada, Roberto
    Sordillo, Emilia Mia
    Tosi, Michael
    Trachtman, Rebecca
    Paniz-Mondolfi, Alberto
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 424 - 433
  • [42] Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis - A Double Whammy!
    Mohta, Alpana
    Dutt Mehta, Rajesh
    Ghiya, Bhikam Chand
    INDIAN PEDIATRICS, 2021, 58 (09) : 894 - 895
  • [43] Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study
    Bagri, Narendra Kumar
    Deepak, Rakesh Kumar
    Meena, Suneeta
    Gupta, Saurabh Kumar
    Prakash, Satya
    Setlur, Kritika
    Satapathy, Jagatshreya
    Chopra, Karan
    Upadhyay, Ashish Datt
    Ramakrishnan, Sivasubramanian
    Lodha, Rakesh
    Dar, Lalit
    Trikha, Anjan
    Kabra, Sushil Kumar
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (03) : 477 - 484
  • [44] Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis — A Double Whammy!
    Alpana Mohta
    Rajesh Dutt Mehta
    Bhikam Chand Ghiya
    Indian Pediatrics, 2021, 58 : 894 - 895
  • [45] Ocular Manifestations of Multisystem Inflammatory Syndrome in Children with COVID-19
    Arkan, Imran
    Demir, Semra Tiryaki
    Livan, Elif Hazal
    Elcioglu, Mustafa Nuri
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (09) : E358 - E358
  • [46] Papilledema associated with COVID-19 multisystem inflammatory syndrome in children
    Chung, Jennifer E.
    Lee, Andrew R.
    Guerriero, Rejean M.
    Reynolds, Margaret M.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (03): : E94 - E96
  • [47] Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19
    Lishman, Juanita
    Kohler, Charles
    de Vos, Corne
    van der Zalm, Marieke M.
    Itana, Justina
    Redfern, Andrew
    Smit, Liezl
    Rabie, Helena
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (12) : E472 - E473
  • [48] Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
    Das, Swarnalata
    Ranjan, Manas Behera
    Das, Palash
    ASIAN JOURNAL OF TRANSFUSION SCIENCE, 2024, 18 (01) : 138 - 140
  • [49] Echocardiographic Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review
    Karimi, Amirali
    Ghafouri, Parham
    Alilou, Sanam
    Rezaei, Nima
    Talesh, Shaghayegh Ashraf
    Ashraf, Haleh
    IRANIAN JOURNAL OF PEDIATRICS, 2022, 32 (02)
  • [50] Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study
    Narendra Kumar Bagri
    Rakesh Kumar Deepak
    Suneeta Meena
    Saurabh Kumar Gupta
    Satya Prakash
    Kritika Setlur
    Jagatshreya Satapathy
    Karan Chopra
    Ashish Datt Upadhyay
    Sivasubramanian Ramakrishnan
    Rakesh Lodha
    Lalit Dar
    Anjan Trikha
    Sushil Kumar Kabra
    Rheumatology International, 2022, 42 : 477 - 484